Jefferies Starts NGM Biopharmaceuticals (NGM) at Buy

July 20, 2022 3:34 AM EDT
Get Alerts NGM Hot Sheet
Price: $5.16 -4.27%

Rating Summary:
    7 Buy, 3 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 12 | Down: 28 | New: 29
Join SI Premium – FREE

Jefferies analyst Dennis Ding initiates coverage on NGM Biopharmaceuticals (NASDAQ: NGM) with a Buy rating and a price target of $25.00.

For an analyst ratings summary and ratings history on NGM Biopharmaceuticals click here. For more ratings news on NGM Biopharmaceuticals click here.

Shares of NGM Biopharmaceuticals closed at $16.03 yesterday.

You May Also Be Interested In

Related Categories

New Coverage